3 UK Penny Stocks With Over £200M Market Cap

Simply Wall St

Thu, December 18, 2025 at 2:05 AM EST 4 min read

The United Kingdom’s stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. In such fluctuating markets, identifying stocks with strong financial foundations becomes crucial for investors seeking stability and potential growth. Despite being an older term, penny stocks continue to attract interest as they often represent smaller or newer companies that can offer significant opportunities when backed by solid fundamentals.

Name	Share Price	Market Cap	Financial Health Rating
Foresight Group Holdings (LSE:FSG)	£4.14	£474.95M	★★★★★★
Warpaint London (AIM:W7L)	£2.00	£161.57M	★★★★★★
On the Beach Group (LSE:OTB)	£2.30	£333.28M	★★★★★★
Ingenta (AIM:ING)	£0.815	£12.3M	★★★★★★
System1 Group (AIM:SYS1)	£2.30	£29.18M	★★★★★★
Integrated Diagnostics Holdings (LSE:IDHC)	$0.675	$392.4M	★★★★★☆
Impax Asset Management Group (AIM:IPX)	£1.466	£177.55M	★★★★★★
Spectra Systems (AIM:SPSY)	£1.48	£71.47M	★★★★★☆
M.T.I Wireless Edge (AIM:MWE)	£0.445	£38.36M	★★★★★★
Begbies Traynor Group (AIM:BEG)	£1.115	£179.44M	★★★★★☆

Click here to see the full list of 306 stocks from our UK Penny Stocks screener.

We’re going to check out a few of the best picks from our screener tool.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Integrated Diagnostics Holdings plc is a consumer healthcare company offering medical diagnostics services, with a market cap of approximately $392.40 million.

Operations: The company’s revenue is primarily generated from Egypt (EGP 5614.74 million), with additional contributions from Jordan (EGP 1005.21 million), Nigeria (EGP 101.12 million), and Saudi Arabia (EGP 39.45 million).

Market Cap: $392.4M

Integrated Diagnostics Holdings plc is a consumer healthcare company with a market cap of approximately $392.40 million, primarily generating revenue from Egypt and other regions like Jordan and Nigeria. The company’s earnings have shown significant growth, rising by 34.3% over the past year, surpassing industry averages. It trades at 75.4% below its estimated fair value, suggesting potential undervaluation in the market. Despite high share price volatility recently, IDHC maintains strong financial health with cash exceeding total debt and robust operating cash flow coverage of debt (842.3%). However, its dividend track record remains unstable despite stable profit margins.